Service Agreement: (name) Pharmacy Service with (name) Mental Health Centre. XXXX Mental Health Trust

1. Agreement Period

January 2000 until March 2001

2. Aim of Agreement

(name) pharmacy department will provide a comprehensive pharmacy service to all XXXX units on this site, which will include a clinical pharmacy service to each ward. The department will also ensure a timely, accurate and economic supply of pharmaceuticals to patients.

3. Parties to the Agreement

Pharmacy Managers P.H.T. (names)

Mental Health Manager (names)

4. Services to be provided

4.1 Routine ward pharmacy visits by a suitably trained pharmacist. Frequency

will be as follows:

Wards a and b 2 visits per week

Ward C 3 visits per week

Ward d once a week

Wards e, f and g daily visits

During each visit all prescriptions will be monitored and individual patient items will be supplied as requested. Items will be supplied the same day.

4.2 Clinical Pharmacy Service: workload permitting the mental health pharmacist will regularly attend ward rounds. Nursing staff will be provided with information and advice regarding the administration and side effects of medications. Patients and/or carers will be counselled as individuals or in groups as needed. The mental health pharmacist will provide literature as requested regarding medication.

4.3 An accurate and timely dispensing service for inpatients, outpatients and TTA prescriptions will be provided, which will conform to the dispensing and checking standards procedures. Two weeks supply will normally be dispensed for TTA's and outpatients prescriptions, although in exceptional circumstances this may be exceeded.

4.4 Stock supply: Technicians will provide a weekly stock topping-up service to each ward, ECT and the day hospitals, which will be delivered in boxes to the ward. Stock will be rotated and expiry dates checked, although it remains the responsibility of nursing staff to ensure products are in date before use. Stock lists will be agreed with ward managers and reviewed at least six monthly.

4.5 Self-Medication: When appropriate patients will be assessed and trained in accordance with Trust policy. A maximum of ten patients in any one period is anticipated, including Kelfield House.

A copy of the Self-Medication Policy is attached.

4.6 Clozapine Clinic: The mental health pharmacist will contribute to the overall smooth running of the Clozapine Clinic. The dispensary staff will be involved in monitoring blood results and dispensing medication in adherence to the CPMS procedures.

4.7 Day hospitals will be visited at least once each month. Individual patient medicines will be dispensed as required. Elderly patients medicines will normally be filled on Mondays and Tuesdays. Acute prescriptions are filled ad hoc.

4.8 Policy and procedure manual: There is a comprehensive green folder of pharmacy policies and procedures available on every ward and day hospital. This includes information on opening hours, on-call arrangements and stock lists.

4.9 Lectures will be given to staff on the Misuse of Drugs Act (1968) up to four time a year as required, in liaison with the Clinical Services Manager.

4.10 Drug Information: A drug information service is available to answer any drug related enquiry from health staff on extension 4035.

4.11 Pharmaceuticals will be procured at optimum prices and with timely delivery.

4.12 Pharmacy staff will meet with nursing and medical staff to discuss/agree policies, procedures and new developments.

4.13 Consent to Treatment: The mental health pharmacist will monitor prescription forms with "Consent to Treatment" or "Second Opinion" forms attached, to ensure that they correspond. Where they do not, the mental health pharmacist will notify either a doctor from the relevant team or the ward manager.

4.14 Pharmacy staff will provide input to junior doctors' induction including completion of drug charts and Clozapine prescriptions.

4.15 FP(10) HP prescription forms will provided to the Walk-in Assessment Centre within the agreed policy.

4.16 An out-of-hours, on-call advisory and dispensing service is provided outside of normal working hours.

5. Quality

5.1 The Clinical Pharmacy Specialist will accompany the mental health pharmacist (Mental health pharmacist) on ward visits twice a year.

5.2 The Mental health pharmacist will train junior members of staff to cover the mental health wards. This will include ward visits and assessments.

5.3 Surveys of outpatient waiting times are conducted 3 monthly.

5.4 An annual audit of doses, which have not been administered to patients, will be carried out on all wards for a one-week period. (known as a "missed doses" study).

5.5 Controlled Drugs will be checked three monthly. Trolley, cupboard and fridge storage will be checked at the same time.

5.6 Comment from patients and carers received during ward visits or training sessions will be fed back to pharmacy and/or mental health management for investigation/action. Formal complaints will be dealt with in compliance with the complaints procedure.

5.7 Clinical audits will be carried out periodically e.g. for D.T.C. or SEPPO.

5.8 The Mental health pharmacist/Pharmacy Manager will attend the XXXX DTC on behalf of (name). They will be expected to provide clinical and financial data in order to facilitate policy decisions and to audit current local practice where required.

5.9 The Mental health pharmacist/Pharmacy Manager will attend the Pharmacy Advisory Group. Performance indicators will be compared within the group to ensure continuous improvement to service.

6.0 Health Promotion

6.1 Counselling of individual patients is available during ward visits in addition to specified training provided to patients and carers.

6.2 Pharmacy will check that all patients on phenothiazines have access to a sun-block preparation.

7.0 Human Resources

7.1 The site Principal Pharmacist is responsible for providing appropriately qualified and trained staff to provide the service. There is a dedicated specialist Mental health pharmacist responsible for training other pharmacy staff.

7.2 Cover will be provided for all services during absence of usual staff with the proviso that consultant ward rounds and training sessions will depend on general workload.

8.0 Equipment and Materials

8.1 Ward boxes and posilocks are supplied by Pharmacy.

8.2 A selection of self-medication aids will be available from Pharmacy: these will be cross charged to Mental Health.

8.3 Pharmacy will provide "green bags" and Controlled Drug stationery.

8.4 Pharmacy will hold all prescription charts, which will be supplied and charged to wards when required.

9.0 Financial Information

9.1 The principal Pharmacist, (name) will send a print-out of the Top 20 items by value to the Mental Health Manager every month. The data will be analysed regularly for trends in expenditure.

9.2 Details of Clozapine patients will be sent monthly to the Mental Health Manager.

10. Communication

10.1 Local personnel (see 10.4) will communicate as necessary regarding issues affecting the SERVICE Agreement.

10.2 Both parties must approve any changes to this agreement.

10.3 An organisation chart is appended to this document.

10.4 Local personnel responsible for this service are:

(name) Principal Pharmacist, X

(name) Mental Health Manager

11. Monitoring Arrangements

11.1 There will be a meeting every 6 months to review service delivery and financial trends and issues.

12. Developments

12.1 The contents of the Emergency Drugs Cupboard at YYYY will be reviewed in line with mental health needs.

12.2 The Mental health pharmacist will attend ward rounds as workload permits on a regular basis.

12.3 The Mental health pharmacist will train junior pharmacists to cover mental health wards.

12.4 Pharmacy will liaise with the Clinical Services Manager on suitable provisions of training to meet the identified needs of mental health in relation to new drugs and updating.

12.5 The potential input of pharmacy to the Community Health Team needs to be discussed at the next review meeting.

12.6 To encourage the improvement of written information that is provided to patients, in liaison with the Drug and Therapeutics Committee.

Signatures: